RIFAXIMIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | RIFAXIMIN |
| DrugBank ID | DB01220 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 24 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| tinea pedis | TxGNN Knowledge Graph | L5 |
| pityriasis versicolor | TxGNN Knowledge Graph | L5 |
| tinea corporis | TxGNN Knowledge Graph | L5 |
| dermatophytosis of groin and perianal area | TxGNN Knowledge Graph | L5 |
| tinea infection | TxGNN Knowledge Graph | L5 |
| retinal neuroblastoma | TxGNN Knowledge Graph | L5 |
| localized pagetoid reticulosis | TxGNN Knowledge Graph | L5 |
| breast carcinoma | TxGNN Knowledge Graph | L5 |
| lymphoma | TxGNN Knowledge Graph | L5 |
| breast neoplasm | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11